etoposide has been researched along with dihydrolipoic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bustamante, J; Orrenius, S; Slater, AF | 1 |
Day, BW; Gantchev, TG; Goldman, R; Kagan, VE; Stoyanovsky, DA; Yalowich, JC | 1 |
Gantchev, T; Kagan, V; Stoyanovsky, D; Yalowich, J | 1 |
3 other study(ies) available for etoposide and dihydrolipoic acid
Article | Year |
---|---|
Antioxidant inhibition of thymocyte apoptosis by dihydrolipoic acid.
Topics: Animals; Antioxidants; Apoptosis; Cell Survival; Cells, Cultured; Chromatin; Etoposide; Glutathione; Glutathione Disulfide; Male; Methylprednisolone; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Thioctic Acid; Thymus Gland | 1995 |
Ascorbate is the primary reductant of the phenoxyl radical of etoposide in the presence of thiols both in cell homogenates and in model systems.
Topics: Animals; Ascorbic Acid; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; Liver; Male; Monophenol Monooxygenase; Oxidation-Reduction; Phenols; Rats; Rats, Sprague-Dawley; Retina; Subcellular Fractions; Sulfhydryl Compounds; Thioctic Acid | 1994 |
Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates.
Topics: Ascorbic Acid; Cell Nucleus; Chromatography, High Pressure Liquid; Deferoxamine; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; Glutathione; Humans; Leukemia; Monophenol Monooxygenase; Oxidation-Reduction; Phenols; Thioctic Acid; Tumor Cells, Cultured | 1993 |